Sona Nanotech Inc. Advances in Cancer Therapy with Targeted Hyperthermia Trials
Sona Nanotech Inc., a company specializing in the materials sector with a focus on metals and mining, has recently made significant strides in the field of oncology. Based in Halifax, Canada, and listed on the Canadian National Stock Exchange, Sona Nanotech is now venturing into innovative cancer therapies using its biocompatible gold nanorod technology.
On June 16, 2025, Sona announced its engagement with Bradford Hill Investigacion Clinica in Santiago, Chile, to conduct a first-in-human early feasibility study for its Targeted Hyperthermia Therapy (THT). This clinical trial aims to assess the safety and potential efficacy of Sona’s THT treatment in up to ten patients with advanced melanoma. The study is set to begin with patient enrollment expected to commence within the month.
Dr. Carlos Rojas, the principal investigator and executive director at Bradford Hill, expressed enthusiasm about the collaboration, highlighting his extensive experience in conducting melanoma clinical trials for leading global pharmaceutical companies. Dr. Rojas emphasized the potential of Sona’s novel cancer treatment and the opportunity to evaluate its effectiveness in a clinical setting.
Sona’s Chief Medical Officer, Dr. Carman Giacomantonio, noted that the primary objective of this early feasibility study is to gather safety data. This initial phase is crucial for determining the viability of further clinical development of the THT treatment.
Sona Nanotech Inc., originally known as Stockport Exploration Inc. before its acquisition by Sona Nanotech Ltd. in 2018, has expanded its operations to explore mineral properties in Kenya, Canada, and Mexico. The company’s pivot towards oncology and life sciences marks a significant diversification of its business activities.
As of June 16, 2025, Sona Nanotech’s stock closed at CAD 0.4, with a market capitalization of approximately CAD 45,805,363. The company’s stock has experienced fluctuations over the past year, reaching a 52-week high of CAD 0.465 on February 17, 2025, and a low of CAD 0.235 on July 29, 2024.
For more information on Sona Nanotech’s activities and initiatives, interested parties can visit their official website at www.stockportexploration.com .